M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.66 EUR -3.28% Market Closed
Market Cap: 106.4m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Wall Street
Price Targets

MAAT Price Targets Summary
Maat Pharma SA

Wall Street analysts forecast MAAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MAAT is 16.15 EUR with a low forecast of 13.94 EUR and a high forecast of 22.05 EUR.

Lowest
Price Target
13.94 EUR
82% Upside
Average
Price Target
16.15 EUR
111% Upside
Highest
Price Target
22.05 EUR
188% Upside
Maat Pharma SA Competitors:
Price Targets
QNCX
Quince Therapeutics Inc
368% Upside
VRTX
Vertex Pharmaceuticals Inc
17% Upside
NTLA
Intellia Therapeutics Inc
321% Upside
002252
Shanghai RAAS Blood Products Co Ltd
7% Downside
DVAX
Dynavax Technologies Corp
95% Upside
FHTX
Foghorn Therapeutics Inc.
108% Upside
VRDN
Viridian Therapeutics Inc
105% Upside
MRUS
Merus NV
96% Upside

Revenue
Forecast

Revenue Estimate
Maat Pharma SA

The compound annual growth rate of Maat Pharma SA's revenue for the next 3 years is 116%.

N/A
Past Growth
116%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Maat Pharma SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Maat Pharma SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MAAT's stock price target?
Price Target
16.15 EUR

According to Wall Street analysts, the average 1-year price target for MAAT is 16.15 EUR with a low forecast of 13.94 EUR and a high forecast of 22.05 EUR.

What is Maat Pharma SA's Revenue forecast?
Projected CAGR
116%

The compound annual growth rate of Maat Pharma SA's revenue for the next 3 years is 116%.

Back to Top